Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Minocycline
Drug ID BADD_D01470
Description Minocycline was first described in the literacture in 1966.[A190681] It is a second generation tetracycline antibiotic that is active against gram-negative and gram-positive bacteria.[A190723] Like other semisynthetic tetracyclines, minocycline has modifications to carbons 7-9 on the D ring to generate higher efficacy than previous tetracyclines.[A190723] Minocycline was granted FDA approval on 30 June 1971.[L11695]
Indications and Usage For the treatment of infections caused by susceptible strains of microorganisms, such as Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsial pox and tick fevers caused by Rickettsiae, upper respiratory tract infections caused by Streptococcus pneumoniae and for the treatment of asymptomatic carriers of Neisseria meningitidis.
Marketing Status Prescription; Discontinued
ATC Code A01AB23; D10AF07; J01AA08
DrugBank ID DB01017
KEGG ID D05045
MeSH ID D008911
PubChem ID 54675783
TTD Drug ID D08LTU
NDC Product Code 42291-591; 42291-589; 69489-201; 72356-101; 49884-512; 72356-103; 63629-2228; 49884-513; 63629-2229; 49884-511
Synonyms Minocycline | Minox 50 | Aknemin | Aknin-Mino | Aknin Mino | Aknosan | Mynocine | Apo-Minocycline | Apo Minocycline | Arestin | Blemix | Cyclomin | Cyclops | Dentomycin | Dynacin | Icht-Oral | Icht Oral | Klinomycin | Lederderm | Mestacine | Minakne | Mino-Wolff | Mino Wolff | Minocin | Minocin MR | Minoclir | Minocycline Hydrochloride | Hydrochloride, Minocycline | Minocycline Monohydrochloride | Monohydrochloride, Minocycline | Minocycline, (4R-(4 alpha,4a beta,5a beta,12a beta))-Isomer | Minolis | Minomycin | Minoplus | Minotab | Akamin | Akne-Puren | Akne Puren
Chemical Information
Molecular Formula C23H27N3O7
CAS Registry Number 10118-90-8
SMILES CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionCytochrome P450 2E1P05181Not Available1421660; 3224399; 1814842
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Pancreatitis07.18.01.0010.001812%
Pancreatitis acute07.18.01.0020.001036%Not Available
Pancytopenia01.03.03.003--Not Available
Papillary thyroid cancer16.24.03.002; 05.02.05.0050.002330%Not Available
Papilloedema24.03.07.001; 06.09.02.002; 17.07.02.0040.002330%
Paraesthesia17.02.06.005--
Pemphigoid23.03.01.004; 10.04.02.0020.000810%Not Available
Pericardial effusion02.06.01.0020.001036%
Pericarditis02.06.02.0010.000518%
Peripheral ischaemia24.04.03.0020.000777%
Peroneal nerve palsy17.09.02.0030.002071%Not Available
Pharyngitis07.05.07.004; 22.07.03.004; 11.01.13.0030.001036%
Photoonycholysis23.02.05.0210.000777%Not Available
Pleural effusion22.05.02.0020.002848%
Pneumonia22.07.01.003; 11.01.09.003--Not Available
Pneumonitis22.01.01.0060.000777%
Pneumothorax22.05.02.0030.000777%
Polyarteritis nodosa24.05.02.011; 20.01.02.004; 15.06.01.003; 10.02.02.0010.027184%Not Available
Polyarthritis15.01.01.0050.004142%Not Available
Polydipsia14.05.02.001; 05.03.03.0020.001036%Not Available
Polyuria20.02.03.0020.000777%Not Available
Proteinuria20.02.01.0110.000777%
Prothrombin time prolonged13.01.02.0120.000518%Not Available
Pruritus23.03.12.001--
Pseudomembranous colitis07.19.01.003; 11.02.02.002--Not Available
Pulmonary embolism24.01.06.001; 22.06.02.001--Not Available
Pulmonary oedema22.01.03.003; 02.05.02.003--
Pupillary reflex impaired06.05.03.009; 17.02.11.0070.000777%Not Available
Pyrexia08.05.02.0030.018122%
Rash23.03.13.0010.010873%Not Available
The 9th Page    First    Pre   9 10 11 12 13    Next   Last    Total 16 Pages